Target intelligence / Profile preview

Lymph node reticular cells and tissue macrophages

Molecular classification
Other
01

Overview

Lymph node reticular cells and tissue macrophages represent a specialized cellular niche within the secondary lymphoid organs, serving as both a structural scaffold and an immunological filter (Fletcher et al., 2015). Fibroblastic reticular cells (FRCs) form a dense network that supports the lymph node architecture and facilitates the transport of small molecules through the conduit system (Girard et al., 2012). These cells also secrete essential chemokines like CCL19 and CCL21 to regulate the trafficking of T cells and dendritic cells. Tissue-resident macrophages, particularly those in the subcapsular and medullary sinuses, are responsible for capturing pathogens and antigens from the lymph, preventing systemic spread and initiating immune responses (Junt et al., 2008). While not a single molecular target, this cellular complex is a focal point for lymph-targeted drug delivery and diagnostic imaging agents. For instance, radiopharmaceuticals like Tilmanocept bind to mannose receptors (CD206) on these macrophages to identify sentinel lymph nodes in cancer staging (FDA, 2013). Understanding the interaction between these stromal and immune cells is vital for developing therapies that modulate lymphatic drainage and immune surveillance.

Other names
Lymph node stromal cellsFibroblastic reticular cellsSubcapsular sinus macrophagesMedullary macrophagesLymph node niche
02

Mechanism of action

Binding to mannose receptors (CD206) on macrophages or phagocytic uptake by the reticuloendothelial system within the lymph node.

03

Biological functions

Immune responseOther
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

Off-target accumulation in the liver and spleenPotential for local inflammatory reactionsInaccurate sentinel node mapping if lymphatic flow is obstructed
06

Interacting drugs

Tilmanocept

2 more in the full profile.

07

Biomarkers

CD169 (Siglec-1)Podoplanin (gp38)CD206 (Mannose receptor)CCL21

Beyond the preview

Go deeper on Lymph node reticular cells and tissue macrophages.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymph node reticular cells and tissue macrophages.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call